Cargando…
Erratum: A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China
Autor principal: | Frontiers Production Office |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947186/ https://www.ncbi.nlm.nih.gov/pubmed/33721001 http://dx.doi.org/10.3389/fphar.2021.654045 |
Ejemplares similares
-
Erratum: Chinese Herbal Medicine for Psoriasis: Evidence from 11 High-Quality Randomized Controlled Trials
por: Frontiers Production Office,
Publicado: (2021) -
A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China
por: Zhang, Nan, et al.
Publicado: (2020) -
Erratum: Exploring the pharmacological action mechanism of Ligusticum Chuanxiong-Piper Longum couplet medicines on the treatment of migraine based on network pharmacology
por: Frontiers Production Office,
Publicado: (2022) -
Erratum: Real-World Prescription Patterns For Patients With Young-Onset Parkinson’s Disease in China: A Trend Analysis From 2014 to 2019
por: Frontiers Production Office,
Publicado: (2022) -
Erratum: The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China
por: Frontiers Production Office,
Publicado: (2022)